Skip to main content
OpenTrials

Clinical trial condition

Lymphoid Interstitial Pneumonia

Explore clinical trials studying Lymphoid Interstitial Pneumonia. Study availability and eligibility vary by location and protocol.

36 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Lymphoid Interstitial Pneumonia trial results

Completed

S0329, Gemcitabine and Paclitaxel in Treating Patients With Persistent, Recurrent, or Metastatic Head and Neck Cancer

NCT00100789

Conditions
Carcinoma, Carcinoma, Squamous Cell, Disease Attributes, +16 more
Locations
  • Northeast Alabama Regional Medical Center Anniston, Alabama, United States
  • Mobile Infirmary Medical Center Mobile, Alabama, United States
  • University of Colorado Cancer Center at University of Colorado Health Sciences Center Aurora, Colorado, United States
  • Veterans Affairs Medical Center - Denver Denver, Colorado, United States
View all 123 locations
View Trial Details
Active, Not Recruiting

Testing the Use of Investigational Drugs Atezolizumab and/or Bevacizumab With or Without Standard Chemotherapy in the Second-Line Treatment of Advanced-Stage Head and Neck Cancers

NCT05063552

Conditions
Carcinoma, Carcinoma, Squamous Cell, Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, +45 more
Locations
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Epic Care-Dublin Dublin, California, United States
  • Epic Care Partners in Cancer Care Emeryville, California, United States
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
View all 172 locations
View Trial Details
Active, Not Recruiting

Durvalumab With Radiotherapy for Adjuvant Treatment of Intermediate Risk SCCHN

NCT03529422

Conditions
Digestive Organs--Diseases, Head and Neck Neoplasms, Laryngeal Diseases, +11 more
Locations
  • University Of Alabama At Birmingham Birmingham, Alabama, United States
  • UNC Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States
  • Medical University of South Carolina - Hollings Cancer Center Charleston, South Carolina, United States
View Trial Details
Active, Not Recruiting

Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

NCT00588770

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +48 more
Locations
  • Providence Hospital Mobile, Alabama, United States
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • Fairbanks Memorial Hospital Fairbanks, Alaska, United States
  • Mercy Hospital Fort Smith Fort Smith, Arkansas, United States
View all 781 locations
View Trial Details

Related conditions